跳至主要内容
临床试验/NCT01520337
NCT01520337已完成不适用

Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy

Cosmo Technologies Ltd0 个研究点目标入组 170 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
170
主要终点
Polyp and adenoma detection rate

研究概览

简要总结

Polyp detection rate in colonoscopy following oral administration of MMX methylene blue tablets

详细描述

Polyp detection rate in colonoscopy following oral administration of methylene blue MMX modified release tablets in subjects undergoing colonoscopy as outpatients.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for screening or surveillance colonoscopy. Written informed consent.Practising reliable contraception or sterile.Ability to understand and comply with the protocol.

排除标准

  • Pregnancy or lactation known or suspected hypersensitivity GI obstruction or perforation serious cardiovascular, renal or hepatic disease. reduced prothrombin time,elevated serum creatinine.

结局指标

主要结局

Polyp and adenoma detection rate

时间窗: 1 day

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验